Yajing Chen
Chief Financial OfficerDr. Yajing Chen, Ph.D., is the Chief Financial Officer of Zai Lab Limited from July 07, 2023. She joined the Zai Lab Limited on September 01, 2021. She is a seasoned finance executive with experience in the life sciences industry as well as a Ph.D. trained scientist. Dr. Chen has served as the Company’s Senior Vice President and Deputy Chief Financial Officer since September 2021, helping to oversee finance, planning and forecasting, accounting, tax, treasury and procurement matters. She worked AstraZeneca where she held various roles of increasing responsibility from 2006 to 2021, including Chief Financial Officer for the U.S. Oncology Business Unit from 2019 to 2021 and Finance Controller of the Global Oncology Business Unit from 2016 to 2019. Dr. Chen earned a Ph.D. in Microbiology from New York University and an MBA from Columbia University.
Positions
- Company NameZai Lab LimitedStock Code09688PositionChief Financial OfficerRelated SecuritiesColleagues
- YDYing DuFounder, Chairperson & CEO
- RGRafael G. AmadoPresident and Head of Global Research & Development
- FTFrazor Titus EdmondsonChief Legal Officer & Corporate Secretary
- CCChristine ChiouSenior VP & Head of Investor Relations
- PKPeter Karl WirthIndependent Director
- JDJohn David DiekmanLead Independent Director
- SWScott William MorrisonIndependent Director
- WDWilliam David LisIndependent Director
